A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pemetrexed|DRUG: Doxorubicin
Sponsor: Eli Lilly and Company